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Summary
Sphingosine kinase is a key enzyme in sphingolipid
metabolism, catalysing the conversion of sphingosine
or dihydrosphingosine into sphingosine-1-phosphate
or dihydrosphingosine-1-phosphate respectively. In
mammals, sphingosine-1-phosphate is a powerful
signalling molecule regulating cell growth, differentia-
tion, apoptosis and immunity. Functions of sphingo-
sine kinase or sphingosine-1-phosphate in pathogenic
protozoans are virtually unknown. While most organ-
isms possess two closely related sphingosine
kinases, only one sphingosine kinase homologue
(SKa) can be identified in Leishmania, which are
vector-borne protozoan parasites responsible for
leishmaniasis. Leishmania SKa is a large, cytoplasmic
enzyme capable of phosphorylating both sphingosine
and dihydrosphingosine. Remarkably, deletion of
SKa leads to catastrophic defects in both the insect
stage and mammalian stage of Leishmania parasites.
Genetic and biochemical analyses demonstrate that
proper expression of SKa is essential for Leishmania
parasites to remove toxic metabolites, to survive
stressful conditions, and to cause disease in mice.
Therefore, SKa is a pleiotropic enzyme with vital
roles throughout the life cycle of Leishmania. The
essentiality of SKa and its apparent divergence from
mammalian counterparts suggests that this enzyme
can be selectively targeted to reduce Leishmania
infection.
Introduction
Trypanosomatid parasites of the genus Leishmania cause
a spectrum of serious diseases (collectively known as
leishmaniasis) infecting 10–12 million people in 88 coun-
tries (Cunningham, 2002). During their life cycle, these
vector-borne protozoans alternate between flagellated
promastigotes which live in the midgut of sandflies and
non-flagellated amastigotes which reside in the phago-
some of mammalian macrophages. Control of leishmania-
sis is hampered by the lack of a safe vaccine, limitations
of frontline drugs, and the emergence of drug resistant
strains (Santos et al., 2008). To develop better treatments,
it is necessary to decipher the molecular strategy utilized
by Leishmania parasites to thrive under the harsh condi-
tions in sandflies and humans.
Sphingolipids (SLs) and their metabolic intermediates
are well-characterized bioactive molecules in mammals
with diverse roles in raft formation, signal transduction,
cell-to-cell recognition, and immune responses (Merrill
et al., 1993; Vaux and Korsmeyer, 1999; Kolter et al.,
2002; Maceyka et al., 2002). Functions of SL metabolism
in Leishmania have been probed using gene knockout
mutants and their reconstituted strains (add-backs). Pre-
viously, a spt2− mutant that lacks an essential subunit
of serine palmitoyltransferase (SPT) was generated in
Leishmania major through targeted gene deletion (Zhang
et al., 2003; Denny et al., 2004). SPT is responsible for
the de novo synthesis of sphingoid bases including
3-ketodihydrosphingosine and dihydrosphingosine (DHS)
(Denny et al., 2004) (Zhang et al., 2003) (Fig. S1), which
are intermediates for the production of high order SLs.
Other sphingoid bases such as sphingosine (Sph) can be
generated through the degradation of ceramide (Mao
and Obeid, 2008) (Fig. S1). Spt2− mutant is replicative in
culture during the logarithmic phase but loses viability
during the stationary phase and fails to differentiate
from non-infective procyclics to infective metacyclics
(a process known as metacyclogenesis in Leishmania
(Sacks and Perkins, 1985)) (Zhang et al., 2003). Very
similar phenotypes are also displayed by another L. major
mutant named spl− which lacks the enzyme sphingosine-
1-phosphate lyase (SPL) (Zhang et al., 2007). SPL
catalyses the hydrolysis of phosphorylated sphingoid
bases such as sphingosine-1-phosphate (S1P) and
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dihydrosphingosine-1-phosphate (DHS1P) (Fig. S1).
Importantly, supplementation of ethanolamine (EtN) com-
pletely reversed the viability and differentiation defects of
both spt2− and spl− promastigotes (Zhang et al., 2007).
After being taken up by cells, EtN can be converted into
EtN-phosphate (EtN-P, a downstream product of SPL;
Fig. S1) and then further utilized to synthesize plasmeny-
lethanolamine (PE), which is an abundant phospholipid in
Leishmania (Zhang et al., 2003; 2007; Gibellini et al.,
2008). Therefore, a main function of sphingoid base syn-
thesis and degradation is to generate EtN-P, a metabolite
essential for phospholipid synthesis and metacyclogen-
esis in Leishmania promastigotes (Fig. S1).
Recently, the turnover of high order SLs was explored in
Leishmania parasites. In L. major, a single inositol phos-
phosphingolipid phospholipase C-like (ISCL) protein is
responsible for the degradation of both inositol phos-
phorylceramide (IPC, the predominant SL in Leishmania)
and sphingomyelin (an abundant SL in mammals) (Zhang
et al., 2009). Null mutants of ISCL (iscl−) grew and differ-
entiated normally as promastigotes but were hypersensi-
tive to acidic pH (Xu et al., 2011). These mutants could not
cause disease in either immunocompetent or immuno-
compromised mice, although they were able to persist at
low levels at the site of infection (Xu et al., 2011). Further
studies demonstrate that the ability to degrade IPC is
important for acid tolerance in promastigotes, and the
ability to degrade host-derived sphingomyelin is required
for amastigote replication and disease development in
mammals (Xu et al., 2011, O. Zhang et al., 2012). A par-
allel study was performed in another Leishmania species,
L. (L) amazonensis, and the phenotype of Laiscl− mutant
mostly mimics that of L. major iscl− except that the
outcome of Laiscl− infection is highly dependent on the
genetic background of mice (Pillai et al., 2012). Together,
these findings strongly suggest that degradation of high
order SLs, especially host-derived sphingomyelin, plays a
pivotal role in the proliferation of Leishmania in mammals
and the manifestation of disease.
In addition to SPT, SPL and sphingomyelinase, another
well-studied enzyme in SL metabolism is sphingosine
kinase (SK) which converts Sph or DHS into S1P or
DHS1P respectively (Maceyka et al., 2002). In organisms
as diverse as mammals, fruit fly, C. elegans and yeasts,
two SK isoforms (SK1 and SK2) are responsible for the
phosphorylation of sphingoid bases using ATP as the
phosphate donor (Maceyka et al., 2002). Mammalian SK1
and SK2 exhibit overlapping substrate specificity but are
not redundant due to different developmental expression,
tissue distribution and subcellular localization (Kohama
et al., 1998; Liu et al., 2000). For example, SK1 is pre-
dominantly cytosolic and can be recruited to the plasma
membrane upon stimulation (Pitson et al., 2005; Stahelin
et al., 2005), while SK2 shuttles between the cytoplasm
and nucleus (Igarashi et al., 2003; Hait et al., 2009). In
mammals, S1P (the product of SK1/SK2) is a potent sig-
nalling lipid that regulates a plethora of important cellular
processes including proliferation, apoptosis, calcium
homeostasis, angiogenesis, platelet formation, cell migra-
tion and immune responses (Strub et al., 2010; Pitson,
2011; L. Zhang et al., 2012). S1P mainly exerts its func-
tion by interacting with a family of cell surface G protein-
coupled receptors (‘inside-out signalling’) to activate
various signalling pathways (Rosen et al., 2009; Strub
et al., 2010). S1P can also act as a second messenger by
regulating intracellular targets such as histone deacety-
lases, mitochondrial prohibitin 2, and tumour necrosis
factor receptor-associated factor 2 (Xia et al., 2002; Hait
et al., 2009; Alvarez et al., 2010; Strub et al., 2011). Due
to S1P’s role in promoting cell survival and proliferation,
human SKs have been developed as therapeutic targets
for the treatment of certain cancer and inflammatory dis-
orders (Shida et al., 2008; Karliner, 2009; Edmonds et al.,
2011). In Saccharomyces cerevisiae, genetic studies
suggest that cytoplasmic S1P can suppress cell growth
and increase heat tolerance at the same time, although
the intracellular targets of S1P in fungi have yet to be
determined (Lanterman and Saba, 1998; Kim et al., 2000;
Birchwood et al., 2001).
In contrast to the wealth of knowledge on S1P signalling
in mammals, functions of SK and S1P have not been
explored in parasitic protozoans such as trypanosomatids
and apicomplexans, which are evolutionarily divergent
from animals and fungi. In this study, we investigated a SK
homologue in L. major named SKa. Based on our previ-
ous findings, SKa should be involved in the conversion of
serine to EtN-P (Fig. S1) (Zhang et al., 2007). Since S1P
regulates numerous processes in mammals, it is tempting
to speculate whether SK/S1P possess any other roles in
addition to EtN-P production. Here our genetic and bio-
chemical analyses demonstrate that Leishmania SKa is a
critically important and pleiotropic enzyme responsible for
the detoxification of sphingoid bases (during the replica-
tive log phase) and the regulation of stress response
(during the non-replicative stationary phase). In addition,
the expression level of SKa needs to be carefully con-
trolled to ensure parasite survival in mice. These findings
add new knowledge to the role of SL metabolism in Leish-
mania and may open doors to new anti-protozoan
treatments.
Results
Identification and genetic manipulation of SKa in
L. major
A single candidate SK gene was identified in the L. major
genome (Tritryp DB system ID: LmjF26.0710) and desig-
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nated as SKa. Syntenic orthologues of SKa are con-
served in other trypanosomatid pathogens including
Leishmania braziliensis, Leishmania infantum, Leishma-
nia mexicana, Trypanosoma brucei and Trypanosoma
cruzi. While most organisms contain two SK isoenzymes,
only one putative SK can be identified in Leishmania spp.
and Trypanosoma spp. With 935 amino acids, the pre-
dicted L. major SKa protein is significantly larger than its
orthologues in mammals and yeasts (Nagiec et al., 1998;
Liu et al., 2002) (Fig. S2). It only shows 22–26% overall
identity to human SK1/SK2 but does contain five con-
served regions (C1-C5 in Fig. S2) and a diacylglycerol
kinase domain (amino acid 343–421, underlined in
Fig. S2B) which are evolutionarily conserved in all SKs
(Pitson, 2011).
To examine the role of SKa, null mutants were gener-
ated in L. major through two rounds of targeted gene
replacement as previously described (Kapler et al., 1990)
(Fig. S3A–C). Southern blot analyses with probes from
the 5′-flanking region and the open reading frame con-
firmed the loss of SKa in two ska− clones (#2-1 and 2-3 in
Fig. S3F–G). To complement these mutants, a high copy
plasmid containing SKa (pXG–SKa) was introduced into
ska− to generate an episomal add-back ska−/ + SKa
(Fig. S3E and G). As expected, these ska−/ + SKa cells
contained many more copies of SKa open read frame
than WT parasites (Fig. S3G). To restore SKa expression
to near-WT level, we inserted a HA-tagged SKa into the
genomic locus of SKa to generate a chromosomal
knockin add-back ska−::HA-SKa (ΔSKa::BSD/ΔSKa::HA-
SKa), using a previously described approach for allelic
replacement in Leishmania (Madeira da Silva et al.,
2009). Southern blot confirmed that these ska−::HA-SKa
parasites had a single copy SKa at the correct locus (in
Fig. S3F–G, the SKa open reading frame in ska−::HA-SKa
is only detectable after 12 h of exposure).
SKa encodes a functional, cytoplasmic SK
To determine if SKa encodes a bona fide SK, we
performed an in vitro activity assay by incubating prom-
astigote lysates with 7-nitro-2-1,3-benzoxadiazol (NBD)-
labelled Sph (Billich and Ettmayer, 2004). Following
extraction, liquids from both the aqueous phase and
organic phase were resolved by thin layer chromatogra-
phy (TLC) (Fig. S4A and B). As expected, the majority of
NBD-S1P was detected in the aqueous phase while the
majority of NBD-Sph was retained in the organic phase.
Compared with WT parasites, ska− mutants had a
reduced yet still detectable level of SK activity (50∼60% of
WT-level) towards Sph and DHS (Fig. 1A–C). Notably, the
chromosomal knockin add-back ska−::HA-SKa showed a
similar SK level as WT parasites, whereas the episomal
add-back ska−/ + SKa exhibited 3–5 time more activity
Fig. 1. SKa encodes a functional SK in
L. major.
A–C. In vitro SK activity assay using
Leishmania lysates. Promastigote lysates
were incubated with NBD-Sph (A) or
NBD-DHS (B) and lipid extraction was
performed as described in Experimental
procedures. Both the aqueous phase (top)
and the organic phase were resolved by TLC
(bottom). Positive control (+): 0.1 unit of
purified human SK2; negative control (−):
boiled WT lysate. These assays were
repeated three times and results were
quantified as μmol (μg × h)−1 and summarized
in C (error bars represent standard
deviations).
D. Metabolism of serine in L. major. Early log
phase promastigotes were labelled with
[3-3H]-serine for 48 h and total lipids were
extracted and resolved by TLC as previously
described (Zhang et al., 2003). O: origin of
migration; F: solvent front.
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than WT (Fig. 1A–C), presumably due to increased SKa
copy number (Fig. S3G). These data suggest that while
SKa encodes an active enzyme which can phosphorylate
both Sph and DHS, it may not be the only SK in L. major.
In a metabolic labelling experiment, live WT and ska−
promastigotes were incubated with [3-3H]-serine for 48 h
and then subjected to lipid analysis by TLC as previously
described (Zhang et al., 2007). As shown in Fig. 1D, WT
parasites could metabolize serine into PE, PC, IPC and
ceramide. In contrast, the incorporation of serine into PE
and PC was much less robust in ska− promastigotes
(Fig. 1D). Meanwhile, a significant accumulation of
labelled sphingoid base was detected in ska− mutants and
this was largely reversed in the ska−/ + SKa parasites
(Fig. 1D). Collectively, these data suggest that L. major
possess more than one functional SK, although only SKa
is recognizable in the genome.
To determine the impact of SKa deletion on lipid syn-
thesis, we examined the composition of major phospho-
lipids by mass spectrometry. As indicated in Fig. S5, the
lipid profile (PE, PI, IPC and ceramide) was not drastically
altered in log phase ska− parasites. This is likely due to the
salvage of phospholipids and SLs from the culture
medium which would bypass the sphingoid base metabo-
lism (see the pathway in Fig. S1), similar to the log phase
spt2− and spl− parasites (Zhang et al., 2007). We also
quantified the abundance of plasmenylethanolamine
(PLE), which is the dominant type of PE in Leishmania
(Zhang et al., 2007). As summarized in Table 1, the level
of PLE in log phase promastigotes of ska− was only
slightly lower than that in WT or ska−/ + SKa parasites (not
statistically significant).
To determine where SKa is expressed in promastigotes
(the sandfly stage), a GFP–SKa fusion protein was intro-
duced into L. major WT parasites (on a high copy-number
plasmid) and the transgenic WT/ + GFP–SKa cells dis-
played a high level of SK similar to that of ska−/ + SKa
(data not shown), indicating that the GFP-fusion protein
was functional. By immunofluorescence microscopy,
GFP–SKa was primarily found in the cytoplasm (Fig. 2A–
D). Similar results were observed when the ska−::HA-SKa
promastigotes were probed with an anti-HA antibody
(Fig. S6), indicating that the cytoplasmic localization is not
an overexpression artefact. To examine the localization of
SKa in amastigotes (the mammalian stage), murine mac-
rophages infected with WT/ + GFP–SKa parasites were
subjected to immunofluorescence analysis using an anti-
GFP antibody. As illustrated in Fig. 2E–I, a clear cytosolic
distribution was detected in intracellular amastigotes.
Therefore, SKa is mainly expressed in the cytoplasm of
Leishmania parasites.
Ska− promastigotes manifest severe growth defect due
to sphingoid base accumulation
Immediately after obtaining the ska− knockout, we noticed
that these mutants could only grow to 6–8 × 106 cells ml−1
in culture, which was only 1/4 to 1/3 of the maximal
density for WT promastigotes (Fig. 3A). Afterwards, they
gradually died in 3–4 days (Fig. 3A and B). When the
viable, log phase ska− promastigotes (at 1–5 × 106
cells ml−1) were inoculated in fresh media at 101–105
cells ml−1, their growth rates and doubling times were
nearly identical to those of WT parasites until culture
densities reached 6–8 × 106 cells ml−1 (Fig. 3A and data
not shown). Importantly, reconstitution of SKa expression
through either chromosomal knockin (ska−::HA-SKa) or
episomal complementation (ska−/ + SKa) fully restored
ska− survival and proliferation in culture (Fig. 3A and B).
Unlike the spt2− or spl− mutants (Zhang et al., 2007), ska−
parasites could not be rescued by exogenous EtN alone
(Fig. 3C and D), indicating that SKa has additional roles
beyond EtN-P production (Fig. S1). Exogenous S1P or
DHS1P also failed to rescue ska− (Fig. S7), suggesting
that the function of SKa is not mediated through
membrane-bound receptors that recognize S1P or
DHS1P. This is consistent with the lack of G-protein
coupled receptors in Leishmania genome (Ivens et al.,
2005).
The rapid demise of ska− after reaching 6–8 × 106
cells ml−1 suggests that certain toxic metabolites are
secreted by the mutant or released from dead parasites.
Indeed, conditioned medium from dying ska− culture was
deleterious to WT promastigotes (‘c’ in Fig. S8). In con-
trast, conditioned medium from healthy, low-density ska−
culture could support parasite growth (‘a’ and ‘b’ in
Fig. S8). Being the substrates of SK, sphingoid bases
such as DHS and Sph are known to exert surfactant
effect (as membrane disruptors) in mammalian cells
(Contreras et al., 2006). They are also potent inhibitors
of protein kinase C (Hannun et al., 1986; Merrill et al.,
1986). In culture, both DHS and Sph exhibited strong
anti-proliferation activities (IC50 = 1–5 μM) against
L. major, L. amazonensis, L. mexicana, and L. donovani
(Fig. S9A–D and data not shown). By comparison, cera-
mides were not nearly as toxic (IC50 > 14 μM) (Fig. S9E
Table 1. Abundance of plasmenylethanolamine or PLE (×107 mol-
ecules per cell).
WT ska− ska−/ + SKa
PLE (early-log) 7.2 ± 0.4 5.0 ± 0.5 6.5 ± 1.8
PLE (mid-log) 6.3 ± 3.0 4.6 ± 2.0 6.8 ± 4.6
Abundance of PLE in early log phase (1–2 × 106 cells ml−1) or mid-log
phase (4–6 × 106 cells ml−1) promastigotes were determined by semi-
quantative mass spectrometry. Average values from two experiments
are summarized with standard deviations.
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and F). These findings, along with the lack of ceramide
accumulation in ska− (Fig. 1D and Fig. S5), suggest that
ceramides are unlikely to be the toxic metabolites.
To examine whether ska− died from sphingoid base
accumulation, myriocin (MYR) was added to promastigote
medium to block the de novo SL synthesis (Fig. S1)
(Zhang et al., 2003). EtN was also provided to ensure
EtN-P production (Fig. S1) (Zhang et al., 2007). Remark-
ably, the combination of MYR (1–10 μM) and EtN (100–
500 μM) completely restored the viability, morphology,
and proliferation rate of ska− (Fig. 3C and D; Fig. 4A and
B) in culture. In addition, these chemically rescued
mutants (ska− + MYR + EtN) produced similar amounts of
metacyclics as WT, ska−::HA-SKa and ska−/ + SKa para-
sites in stationary phase (Fig. 4A). Without EtN, MYR
alone partially rescued the growth and survival of ska− but
not metacyclogenesis (Fig. 4A and B), which was similar
to the spt2− mutant and in agreement with our previous
finding that EtN-P production is required for differentiation
(Zhang et al., 2007). Based on these findings, we con-
clude that a crucial role of SKa in Leishmania promastig-
otes is to avert the accumulation of toxic sphingoid bases
(Fig. S1). The fact that ska− mutants still possess signifi-
cant SK activity (Fig. 1) suggests that even a partial inhi-
bition of SK can be detrimental to Leishmania. Unless
otherwise specified, MYR (1 μM) and EtN (200 μM) were
provided to ska− promastigote cultures in all the studies
described below.
Ska− promastigotes are extremely vulnerable to stress
To establish infection and proliferate in the mammalian
host, Leishmania parasites must develop resistance to
various stress conditions including elevated temperature,
Fig. 2. Cytoplasmic localization of the SKa
protein. WT/ + GFP–SKa promastigotes (A–D)
or WT/ + GFP–SKa-infected MΦs (E–I) were
permeabilized and subjected to
immunofluorescence microscopy. (A and E)
Differential interference contrast images; (B
and F) DNA staining with Hoechst 33242; (C
and G) rabbit anti-GFP polyclonal antibody
labelling followed by incubation with a Texas
red-conjugated goat anti-rabbit IgG antibody;
(D) GFP fluorescence; (H) overlay of F and
G; (I) enlarged image of the framed area in H.
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acidic pH and increased concentration of reactive oxygen
species/reactive nitrogen species. To investigate if SKa
was required for thermotolerance, L. major promastigotes
were cultured to stationary phase at 27°C (the regular
temperature for promastigotes) and then exposed to
higher temperatures (33°C or 37°C). As illustrated in
Fig. 5A, the majority of ska− mutants (55–74%) lost viabil-
ity at 37°C in 24 h, whereas WT, ska−::HA-SKa and
ska−/ + SKa parasites were mostly alive (only 14–22%
death). Meanwhile, ska− mutants survived much better
after exposure to 33°C (Fig. 5A). To test whether SKa was
involved in acid resistance, stationary phase promastig-
otes were transferred from a neutral medium (pH 7.4, the
regular pH for promastigote medium) to an acidic medium
(pH 5.0). Significantly, ska− mutants failed to adapt and
66–73% of them died within 24 h (Fig. 5B). In contrast,
only 4–12% of WT and ska−/ + SKa cells were dead fol-
lowing the same treatment (Fig. 5B). We also evaluated
the ability of ska− mutants to survive oxidative and
nitrosative stress. As shown in Fig. 5C and D, these
knockout parasites were hypersensitive to S-nitroso-N-
acetylpenicillamine (a nitric oxide releaser) and hydrogen
peroxide. Therefore, although ska− mutants supple-
mented with MYR and EtN could replicate and differenti-
ate normally in culture, they were highly susceptible to
stress.
As a control, WT promastigotes grown in the presence
of MYR and EtN did not exhibit any significant difference
in those tests (Fig. S10), indicating that the stress
response defect of ska− is not caused by MYR and EtN
(Fig. 5). In addition, exogenous sphingoid bases or cera-
mides had little effect on WT parasites in stress response
(Fig. S10). Together, these findings suggest that it is the
production of S1P (not the accumulation of sphingoid
base) that is crucial for Leishmania to adapt to conditions
in the mammalian host.
Surface virulence factors in Leishmania including
lipophosphoglycan (LPG) and glycoprotein 63 (GP63) are
known to confer resistance to oxidants, complements,
and alter host signalling pathways (Spath et al., 2003;
Gomez et al., 2009). To examine whether SKa played a
role in the synthesis of GPI-anchored molecules, promas-
tigote lysates were subjected to Western-blot analysis
using antibodies against LPG and GP63. As illustrated in
Fig. S11, cellular levels of LPG and GP63 in ska− and
ska−/ + SKa were comparable to those in WT parasites,
suggesting that deletion or overexpression of SKa had no
adverse effect on the expression of GPI-anchored surface
virulence molecules.
Ska− and ska−/ + SKa parasites fail to cause disease in
susceptible mice while the ska−::HA-SKa parasites are
fully infective
The impact of SKa on L. major virulence was evaluated by
macrophage infection and footpad infection of susceptible
BALB/c mice. As shown in Fig. 6A and B, stationary phase
ska− promastigotes (complemented with MYR + EtN)
were able to invade and survive in murine macrophages
(derived from the bone marrow of BALB/c mice) at a
similar level as WT and ska−/ + SKa parasites. Apparently,
ska−’s deficiency in stress response (summarized in
Fig. 3. Loss of SKa leads to catastrophic
defects in culture due to sphingoid base
accumulation. (A and B) Ska− mutants exhibit
severe growth defects in culture.
Promastigotes were inoculated at 1.0 × 105
cells ml−1 and incubated at 27°C. Culture
densities (A) and percentages of dead cells
(B) were monitored daily. (C and D) Rescue
of ska− mutants by MYR + EtN. Ska−
promastigotes were inoculated at 1.0 × 105
cells ml−1 in the presence of EtN (200 μM),
MYR (1 μM) or EtN + MYR (200 and 1 μM
respectively) and incubated at 27°C. Culture
densities (C) and percentages of dead cells
(D) were monitored daily. These experiments
were repeated 4–5 times and error bars
represent standard deviations.
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Fig. 5) does not affect their ability to parasitize macro-
phages in this short in vitro assay (3–4 days).
However, these ska− mutants (stationary phase prom-
astigotes) failed to generate any pathology in BALB/c
mice (after 20 weeks), which were highly susceptible
to WT infection (Fig. 7A). Curiously, although the
ska−/ + SKa parasites (the episomal add-back) were com-
pletely normal as promastigotes in culture, they did not
reverse the virulence defect of ska− (Fig. 7A). Only the
ska−::HA-SKa cells (the chromosomal knockin add-back)
induced progressive footpad lesions (similar to WT) which
correlated with the increasing number of parasites
(Fig. 7A and B). Very similar results were obtained when
mice were infected with purified metacyclics of WT, ska−
or ska−/ + SKa (Fig. S12A). Despite their lack of virulence,
both ska− and ska−/ + SKa parasites were able to persist
at low levels in mice (1–600 parasites/footpad) (Fig. 7B
and Fig. S12B). Finally, parasites recovered from
ska−/ + SKa-infected mice (after 5–20 weeks) still con-
tained the pXG–SKa episome (data not shown), ruling out
the possibility of plasmid loss. The fact that only the chro-
mosomal knockin add-back restores virulence suggests
that in order to be functional during the mammalian stage,
SKa must be expressed at near-WT level and/or from its
endogenous locus.
Discussion
Previous studies of the spt2− and spl− mutants demon-
strate that a major role of sphingoid base metabolism in
Leishmania is to provide EtN-P, which is probably used to
synthesize PE and PC (Zhang et al., 2007). Here we
investigated the function of SK in Leishmania using
reverse genetic approaches. SKs are conserved lipid
kinases catalysing a key step in SL metabolism, i.e. the
formation of S1P or DHS1P from Sph or DHS (Fig. S1).
While most organisms possess two closely related SK
isoforms, only one SK homologue (SKa) can be identified
in Leishmania genome. Overexpression of SKa in
L. major led to increased SK activity but no obvious
defects in culture. SKa-null mutants (ska−) showed
reduced SK activity but could still metabolize serine into
downstream products including ceramide, IPC, PE and
PC (Fig. 1). Remarkably, this partial block of SK activity
was sufficient to cause a devastating consequence to
ska− promastigotes, as these mutants only grew to 1/4 to
1/3 of WT-level in culture and then died in 3–4 days
(Figs 3 and 4). Further studies indicate that this cata-
strophic defect was likely due to the accumulation and
release of toxic sphingoid bases generated from de novo
synthesis (Figs 3 and 4; Figs S7–S9). To alleviate this
problem, MYR and EtN were supplemented to ska− to
inhibit sphingoid base synthesis without compromising
EtN-P production. Our results suggest that during the
replicative log phase, Leishmania promastigotes must
maintain a robust level of SKa to: (i) fulfil the need for
EtN-P production and phospholipid synthesis; and (ii)
eliminate free sphingoid bases to avoid cytotoxicity.
Besides detoxification, SKa also plays an important role
in the stress response of non-replicative, stationary phase
promastigotes. While ska− promastigotes supplemented
with MYR + EtN replicated and differentiated normally in
culture, they were hypersensitive to heat, acidic pH, oxi-
dants and nitrosative stress (Fig. 5). These defects are
not caused by the accumulation of MYR, EtN, sphingoid
bases, or ceramides (Fig. S10). Therefore, in addition to
being intermediates for EtN-P production, S1P or DHS1P
Fig. 4. Ska− mutants supplemented with MYR and EtN show
normal metacyclogenesis.
A. Percentages of metacyclics were determined daily from
stationary phase cultures of WT, ska− (supplemented with 1 μM of
MYR only or 1 μM of MYR + 200 μM of EtN), ska−/ + SKa, and
ska−::HA-SKa using the density centrifugation method. Experiments
were performed in triplicates and error bars represent standard
deviations.
B. Representative differential interference contrast images of cells
from day 3 stationary phase cultures.
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may act as central regulators controlling the transition of
Leishmania from insect stage to mammalian stage. In
mammals, S1P exerts its function by binding to cell mem-
brane receptors or intracellular targets. The cytoplasmic
localization of SKa (in both promastigotes and amastig-
otes) suggests that the target of S1P/DHS1P in Leishma-
nia is cytosolic, which is consistent with the lack of
G-protein coupled membrane receptors in the annotated
genomes of trypanosomatids. It is worth mentioning that
the spt2− mutants or WT parasites grown in the presence
of MYR (defective in the de novo synthesis of sphingoid
bases) did not exhibit any deficiency in resistance to heat,
acidic pH, or oxidative/nitrosative stress when grown in
the presence of EtN (data not shown). These findings
suggest that Leishmania parasites can salvage sufficient
amount of sphingoid bases to satisfy the need for S1P or
DHS1P in stress tolerance. Alternatively, SKa protein may
possess a secondary function that is vital for stress
response yet independent of SK activity, which may
explain its significant sequence divergence from other
SKs (Fig. S2). Future studies will attempt to identify the
proteins that bind SKa and/or its products (S1P/DHS1P),
which may lead to new light on the role of sphingolipid
metabolites in a protozoan parasite.
Although the ska− mutants (when supplemented with
MYR + EtN) could invade murine macrophages and
survive well for 3–4 days in vitro, they completely failed to
proliferate or cause disease in BALB/c mice (Figs 6 and
7). Such a severe virulence defect is in line with their
inability to adapt to mammalian conditions. While the
accumulation of sphingoid bases in ska− is clearly detri-
Fig. 5. Ska− mutants are hypersensitive to
stress conditions. (A and B) Promastigotes
were cultured under regular condition (27°C,
pH 7.4) to stationary phase before stress
treatments. In A, parasites were transferred to
37°C, 33°C, or remained at 27°C. In B, half of
the parasites were transferred to an acidic
medium (pH 5.0) while the other half
remained in regular medium (pH 7.4) for 72 h
at 27°C. (C and D) Stationary phase
promastigotes were challenged with various
concentrations of SNAP (C) or hydrogen
peroxide (D). In all experiments, ska−
promastigotes were complemented with 1 μM
of MYR + 200 μM of EtN; percentages of cell
death were determined at 24 h (A), 48 h (C
and D), or 72 h (B) post treatments; and error
bars indicate standard deviations from three
independent repeats.
Fig. 6. Ska− mutants supplemented with MYR and EtN survive
well in MΦs in vitro. (A and B) Stationary phase promastigotes
were used to infect bone-marrow derived MΦs (from BALB/c mice)
as described in Experimental procedures. Percentage of infected
MΦs (A) and the number of parasites in 100 MΦs (B) were
recorded at 2, 24, 48 and 72 h post infection. As a control, WT
promastigotes were also used to infect activated MΦs
(pre-stimulated with 100 ng ml−1 of LPS and 100 ng ml−1 of IFN-γ).
Error bars represent standard deviations.
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mental to promastigotes, it is unlikely to be a major factor
during the mammalian stage because the de novo syn-
thesis of sphingoid base is greatly downregulated in
amastigotes (which acquire EtN through salvage) (Zhang
et al., 2005; 2007). Interestingly, only the chromosomal
knockin add-back displayed WT-level infectivity while the
episomal add-back failed to produce any pathology in
mice (Fig. 7), despite the fact that both add-back para-
sites showed WT-like phenotypes in culture, e.g. in growth
and stress response. It is possible that the flanking
sequences of SKa open reading frame play a crucial role
in the post-transcriptional regulation of SKa during the
amastigote stage, such as ensuring mRNA stability and
translation efficiency. This type of gene expression control
is not uncommon among trypanosomatids (McNicoll et al.,
2005; Haile et al., 2008) and may explain why SKa must
be at its endogenous locus to be fully functional. Alterna-
tively, the over expression of SKa may have deleterious
consequences in the episomal add-back parasites during
the amastigote stage (although it is well tolerated by pro-
mastigotes). In mammals, the synthesis of S1P is tightly
regulated both spatially and temporally to limit any poten-
tial adverse effects from this powerful signalling molecule
(Strub et al., 2010; Pitson, 2011; Siow et al., 2011).
Further studies will shed light on the regulation and
target(s) of SKa, which should expand our current knowl-
edge on sphingoid metabolism in non-mammalian
systems.
In summary, SKa is an extraordinarily important
enzyme in both the promastigote stage and amastigote
stage of Leishmania because: (i) a robust level of SKa is
necessary to remove toxic sphingoid base from replicat-
ing promastigotes which have a high demand for EtN-P;
(ii) SKa is also required the non-replicating promastigotes
to survive elevated temperature, acidic pH and increased
concentrations of reactive oxygen intermediates/reactive
nitrogen intermediates; and (iii) the expression of SKa
must be carefully regulated during the mammalian stage
to ensure amastigote proliferation and disease progres-
sion. Since SKa is only marginally related to human SKs,
it is tempting to consider its potential as a drug target.
While even a partial inhibition of SK is detrimental to
Leishmania, genetic deletion of either SK1 or SK2 leads
to no obvious defects in mice and only the double knock-
out is lethal (Mizugishi et al., 2005). Therefore, mammals
may be more tolerant to SK inhibitors than Leishmania. It
is also of note that human SKs have been explored as
targets for immunomodulatory drugs (e.g. FTY720) and
anti-tumour drugs (Shida et al., 2008; Pitman and Pitson,
2010; Pyne and Pyne, 2011; Raje et al., 2012), using
fluorescence-based, high throughput SK assays that are
commercially available. In the future, to evaluate its
potential as a new anti-Leishmania target, it is necessary
to purify recombinant SKa. Although SKa is predicted to
be a large protein (101 kDa), the lack of transmembrane
domains and its cytoplasmic localization suggest the
recombinant enzyme can be soluble.
Given the importance of SKa, future studies will also
focus on other enzymes involved in the dynamics of
sphingoid bases and S1P. For instance, the phenotype of
ska− mutants suggests that although a second SK exists
in Leishmania, it is not sufficient to detoxify sphingoid
bases or control stress response when it is expressed at
the endogenous level. While most organisms (including
human, slime mould, worms, fruit fly and yeast) possess
two isoforms of SK that share a high degree of sequence
similarity (Hait et al., 2006), the second SK cannot be
readily identified in the genomes trypanosomatid para-
sites. Future investigations may reveal why these proto-
zoans produce two highly divergent SKs in the context of
enzymatic specificity, parasite physiology and evolution.
Another enzyme of interest would be the S1P phos-
phatase which catalyses the degradation of S1P. Along
with the S1P lyase (SPL), S1P phosphatase counters the
activity of SK by reducing S1P level therefore controls
the cellular concentrations of sphingoid bases and their
phosphorylated products. Characterization of enzymes
involved in sphingoid base metabolism would improve our
understanding on Leishmania biology and expand our
knowledge on SL-mediated signalling.
Fig. 7. Ska− and ska−/ + SKa parasites fail to
cause pathology in BALB/c mice while the
chromosomal knockin (ska−::HA-SKa) is fully
virulent. BALB/c mice were infected in the
footpads with stationary phase promastigotes
(1.0 × 106 cells per mouse, 5 mice per group).
A. Lesion sizes of infected footpads were
measured weekly with a caliper.
B. Parasite numbers in the infected footpads
were determined at 6 or 20 weeks post
infection (w P.I.) by limiting dilution assay.
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Experimental procedures
Ethics statement for mouse use
The use of mice in this study was approved by the Animal
Care and Use Committee at Texas Tech University (US PHS
Approved Animal Welfare Assurance NO. A3629-01). BALB/c
mice (female, 7–8 weeks old) were purchased from Charles
River Laboratories International. Mice were housed and
cared for in the facility operated by the Animal Care and
Resources Center at Texas Tech University adhering to the
Guide for the Care and Use of Laboratory Animals (the 8th
Edition, NRC 2011) for animal husbandry. The facility was
inspected monthly and animals were monitored daily by staff
members. A complete range of clinical veterinary services
was available on a 24 h basis including consultation, diag-
nostic work-up and clinical care. Lab personnel participating
in this study are trained to use proper restraining and injection
techniques to reduce pain and distress of animals without
compromising the quality of research. Mice were anesthe-
tized (through the intraperitoneal injection of 100 mg kg−1 of
ketamine hydrochloride and 10 mg kg−1 of xylazine) prior to
the injection of Leishmania parasites into footpads, the recov-
ery of parasites from infected mice, and the measurement of
lesion size using a caliper. Usually, no more than one proce-
dure was performed on any mouse within a week. Mice were
monitored twice a week for appearance, size, movement and
general health condition. Mice were euthanized by carbon
dioxide asphyxiation when footpad lesions became over
2.5 mm or when secondary infection was detected. Mice
were also euthanized prior to the isolation of femur cells and
limiting dilution assay (to determine parasite load in infected
tissue).
Materials
Omega(7-nitro-2-1,3-benzoxadiazol-4-yl) (2S,3R,4E)-2-
aminooctadec-4-ene-1,3-diol (C18 NBD-sphingosine)
and omega(7-nitro-2-1,3-benzoxadiazol-4-yl) (2S,3R)-2-
aminooctadecane-1,3-diol (C18 NBD-dihydrosphingosine)
were purchased from Avanti Polar Lipids (Birmingham, AL).
Human recombinant SK2 and ATP were purchased from
Sigma-Aldrich. L-[3-3H(G)]-serine (23Ci mmol−1) was pur-
chased from Perkin Elmers. All other chemicals were pur-
chased from VWR International or Fisher Scientifics unless
specified otherwise.
Molecular constructs
The open reading frame (ORF) of SKa (LmjF26.0710) was
amplified by PCR from L. major genomic DNA using primers
P207 (attactggatccaccATGCACTCTCTCAGCTCC) and
P210 (attactggatccCTACCCACTGCGCACGAACTG). The
resulting 2.8 kb DNA fragment was digested with BamHI and
cloned into the pXG vector (Ha et al., 1996) as pXG–SKa
(B195). After confirming its sequence, the SKa ORF was
subcloned into the pXG–GFP+2′ vector (Ha et al., 1996) to
generate pXG–GFP–SKa (B285), which was used in locali-
zation studies. To generate SKa knock-out constructs, the
predicted 5′- and 3′-flanking sequences (∼ 800 bp each) were
PCR amplified and cloned in tandem into the pUC18 vector.
Genes conferring resistance to puromycin (PAC) and blasti-
cidin (BSD) were then inserted between the 5′- and 3′-
flanking sequences to generate pUC-KO-SKa:PAC (B225)
and pUC-KO-SKa:BSD (B224) respectively. In addition, a
HA-tagged SKa ORF and its 5′-flanking sequence were
cloned into the pGEM-phleo-HA′ (B202) vector (Madeira da
Silva et al., 2009) to generate pGEM-5′UTR-phleo-HA-SKa
(B289). This construct was used to express SKa from its
chromosomal locus (Madeira da Silva et al., 2009).
Leishmania culture and genetic manipulations
Leishmania major FV1 (MHOM/IL/81/Friedlin) wild type (WT)
promastigotes were grown in M199 medium with 10% fetal
bovine serum (FBS) and other supplements as previously
described (Kapler et al., 1990). Unless specified otherwise,
ska− mutants were grown in the presence of 1 μM of MYR
and 200 μM of EtN. Treatment with MYR and EtN had no
detectable effect on the proliferation, differentiation, or infec-
tivity of WT parasites (data not shown). Promastigote repli-
cation was determined by monitoring culture density over
time using a haemacytometer. Cell viability was examined by
flow cytometry (using an Accuri C6 flow cytometer) after
staining with 5 μg ml−1 of propidium iodide. Metacyclics were
isolated from the stationary phase culture by the density
gradient centrifugation method (Spath and Beverley, 2001) or
the peanut agglutination method (Sacks et al., 1985). The two
SKa alleles in WT parasites were sequentially replaced by
PAC and BSD resistance genes to generate the ska− mutant
(ΔSKa::PAC /ΔSKa::BSD). Transfection and selection of
drug-resistant promastigotes were performed as previously
described (Kapler et al., 1990). To confirm SKa deletion in
ska−, genomic DNA was digested with ScaI, resolved on a
0.7% agarose gel, transferred to a nitrocellulose membrane,
and hybridized with a 32P-labelled DNA probe corresponding
to either the SKa ORF or the 5′-flanking sequence. To restore
SKa expression via episomal overexpression, pXG–SKa
was transfected into the mutant and the resulting add-
back parasite (resistant to G418) was referred to as
ska−/ + SKa (ΔSKa::BSD/ΔSKa::PAC+ pXG–SKa). To restore
SKa expression to near WT-level, we generated a SKa chro-
mosomal knockin by integrating a HA-tagged SKa ORF into
the genomic locus of SKa as previously described (Madeira
da Silva et al., 2009). To do so, the plasmid DNA of pGEM-
5′UTR-phleo-HA-SKa was linearized with EcoRI and intro-
duced into the SKa heterozygote parasites (ΔSKa::BSD/
SKa); cells showing resistance to blasticidin and phleomycin
were selected; finally, these knockin parasites were con-
firmed by Southern-blot and designated as ska−::HA-SKa
(ΔSKa::BSD/ΔSKa::HA-SKa). To study SKa localization,
pXG–GFP–SKa was transfected into WT parasites to gener-
ate WT/ + GFP–SKa parasites (resistant to G418).
SK activity assay
Log phase promastigotes (1–4 × 106 cells ml−1 in culture)
were resuspended in a lysis buffer (50 mM HEPES pH 7.4,
800 mM KCl, 2 mM dithiothreitol, 2 mM ATP, 0.02% Triton
X-100, 20 mM MgCl2, 20 mM NaF and 2× protease inhibitor
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cocktail) at 4.0 × 108 cells ml−1 and incubated on ice for 5 min.
Protein concentration was determined by the BCA assay
(Pierce). SK assay was performed as previously described
with minor modifications (Billich and Ettmayer, 2004). Briefly,
C18 NBD-Sph or C18 NBD-DHS was prepared in 4 mg ml−1
low fat bovine serum albumin at a final concentration of
30 μM. Each assay reaction contained 25 μl of Leishmania
cell lysate (∼ 40 μg of total protein) and an equal volume of
C18 NBD-Sph or C18 NBD-DHS. After 30 min incubation at
27°C, the reaction was terminated by adding 50 μl of K2HPO4
(1 M, pH 8.5) and 250 μl of chloroform : methanol (2:1). After
centrifugation (13 000 g, 2 min), the upper aqueous phase
(containing NBD-labelled S-1-P or DHS-1-P) was separated
from the lower organic phase (containing NBD-labelled sub-
strates). Fractions of upper phase and lower phase were
loaded separately on aluminum-backed silica gel plates
(Sigma-Aldrich). NBD-labelled products/substrates were
separated by thin layer chromatography (solvent: chloroform/
methanol/ammonium hydroxide = 10/10/3) and detected with
a Storm 860 phosphoimager. 0.1 unit of recombinant human
SK2 was used as a positive control and boiled WT lysate
(∼ 40 μg of total protein) was used as a negative control. SK
activity [nmol (μg × h)−1] was calculated based on the amount
of NBD S1P or NBD DHS1P produced in each reaction after
subtracting the value of negative control.
Metabolic labelling with [3-3H]-serine
Promastigotes were inoculated at 1.0 × 105 cells ml−1 and
labelled with 1.5 μCi ml−1 of L-[3-3H(G)]-serine. After 48 h,
parasites were harvested and total lipids (from ∼ 1 × 108 cells)
were extracted using the Bligh-Dyer method (Bligh and Dyer,
1959). TLC was performed as previously described (Zhang
et al., 2007).
Lipid analysis by electrospray ionization mass
spectrometry (ESI-MS)
Lipid extraction and analysis by ESI-MS (negative ion
mode) were performed similarly as previously described
(Zhang et al., 2007). A 1-O-1′-(Z)-octadecenyl-2-arachidoyl-
sn-glycero-3-phosphoethanolamine (p18:0/20:4-PE, FW =
751.6, Avanti Polar Lipids) was used as a standard to quantify
PLE. This standard was added to cell lysates prior to lipid
extraction (at 1.0 × 108 molecules per cell).
Immunofluorescence microscopy
To determine the localization of SKa in promastigotes, log
phase parasites of WT/ + GFP–SKa or ska−::HA-SKa were
fixed in 3.7% formaldehyde, attached to poly-L-lysine coated
coverslips, and permeabilized with 0.5% Triton X-100 (pre-
pared in PBS) at room temperature for 15 min. Immunofluo-
rescence microscopy was performed as previously described
(Zhang et al., 2003). Primary antibody: rabbit anti-GFP poly-
clonal antibody (1:1000, Life Technologies) or rabbit anti-HA
polyclonal antibody (1:50, Life Technologies). Secondary
antibody: goat anti-rabbit IgG-Texas Red (1:1000, Life Tech-
nologies).
To determine the localization of SKa in amastigotes, THP-1
derived macrophages were infected with stationary promas-
tigotes (10 parasites per macrophage) and incubated at
37°C/5% CO2 for 48 h. Macrophages were then fixed in 3.7%
formaldehyde and permeabilized with ice-cold ethanol for
15 min. Immunofluorescence assay was then performed as
described above.
Leishmania stress response
Promastigotes were grown in regular medium (M199/10%
FBS and supplements, pH 7.4) at 27°C to stationary phase
(culture density = 2.0–3.5 × 107 cells ml−1) and used in the
following assays. To test temperature sensitivity, parasites
were kept in regular medium and incubated at 27°C, 33°C/5%
CO2, or 37°C/5% CO2 (Xu et al., 2011). To examine their
tolerance to acidic pH, parasites were either kept in regular
medium (pH 7.4) or transferred to a pH 5.0 medium (same as
the regular medium except the pH was modified with hydro-
chloric acid) and incubated at 27°C (Xu et al., 2011). To
measure their sensitivity toward oxidative and nitrosative
stress, parasites were cultured in 24-well plates (regular
medium, 27°C) in the presence of 0–500 μM of H2O2 or
S-nitroso-N-acetylpenicillamine (SNAP) (Xu et al., 2011). Cell
density and viability were determined at the indicated time
points.
Murine macrophage (MΦ) infection
Bone marrow-derived MΦs were generated from the femur
cells of BALB/c mice in complete DMEM/10% FBS +
20 ng ml−1 macrophage colony-stimulating factor for 4 days at
37°C/5% CO2. Infection was performed with late stationary
phase parasites (opsonized with C57BL6 mouse serum) at a
ratio of twenty parasites per one MΦ as previously described
(Racoosin and Beverley, 1997). MΦs were then incubated at
33°C/5% CO2 for 3 days. Percentages of infected MΦs and
the number of parasites per 100 MΦs were determined by
microscopy after staining with 1 μg ml−1 of Hoechst 33342.
Mouse infections and analyses
Stationary phase promastigotes were inoculated into BALB/c
mice (2–5 × 107 cells per mouse) and recovered after 3–4
weeks. Virulence of these low passage parasites (in vitro
passages < 5) was evaluated by footpad infection as previ-
ously described (Titus et al., 1991), using either stationary
promastigotes (1 × 106 cells per mouse, 5 mice per group) or
purified metacyclics (2 × 105 cells per mouse, 5 mice per
group). Footpad lesions were measured weekly using a
vernier caliper and parasite numbers were determined by
limiting dilution assay (Titus et al., 1985).
Western blot
To determine the expression level of GPI-anchored mol-
ecules, promastigotes were harvested and Western blot
analyses were performed with antibodies against LPG or
GP63 as previously described (Zhang et al., 2004).
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